What Prompted DuPont (NYSE:DD) to Raise Its 2026 EPS Outlook to USD 7.47 to 7.52?

Vinay Lochav

05 November 2026 12:48 AM AEDT

What Prompted DuPont (NYSE:DD) to Raise Its 2026 EPS Outlook to USD 7.47 to 7.52?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

DuPont (NYSE:DD) set a new 2026 adjusted Earnings range of USD 7.47 to USD 7.52, against a published consensus of USD 7.25, on Revenue of about USD 7.19 billion.
Third-quarter adjusted earnings were USD 2.09 a share, with net sales of about USD 1.9 billion, up 4%, and organic growth of 5%.
Operating EBITDA reached USD 469 million, up 8% from USD 436 million, with the Margin up 80 basis points to 25.1%.
Fourth-quarter adjusted earnings guidance is USD 1.90 to USD 1.95 a share, with another USD 250 million of repurchases planned after a USD 250 million accelerated programme.

What DuPont Reported

DuPont reported third-quarter 2026 results on November 3, 2026. Net sales were about USD 1.9 billion, up 4%, with organic growth of 5% and a 1% currency drag. Adjusted earnings were USD 2.09 a share, ahead of consensus, while GAAP earnings of USD 1.24 a share fell short. Operating EBITDA was USD 469 million, up 8%. Operating Cash Flow from continuing operations was USD 410 million, and transaction-adjusted free cash flow was USD 341 million, a conversion rate of 121%. The shares rose on the day, though reports differ on the size, with one market recap showing 8.6% and one earnings report citing 2.4%. Capital return also continued: a USD 250 million accelerated share repurchase was completed, and about USD 100 million of open-market purchases were substantially completed in the quarter, which supports per-share earnings alongside operating gains.

What Changed in the Outlook

For 2026 DuPont now guides adjusted earnings of USD 7.47 to USD 7.52, revenue of about USD 7.19 billion and organic growth of about 4.5%, against published consensus of USD 7.25 and USD 7.16 billion. Published coverage calls the guidance raised again, but the prior range was not available to confirm. Fourth-quarter guidance of USD 1.90 to USD 1.95 a share has a midpoint of USD 1.93, above the USD 1.88 consensus. Margins are doing the heavy lifting: operating EBITDA grew twice as fast as sales, which is how Operating Leverage lifts earnings when volumes recover. The fourth-quarter revenue guide of about USD 1.82 billion is in line with estimates, so the upside to the outlook comes from earnings rather than sales, a point worth weighing for DuPont (NYSE:DD).

Risks and Signals to Track

Organic growth of about 4.5% is modest, so earnings depend on cost control and buybacks. Share repurchases, including the completed USD 250 million accelerated programme, cut the share count and lift earnings a share without lifting profit, so earnings quality deserves attention when growth is about 4.5%. GAAP earnings missed estimates, which shows adjustments matter. The conflicting stock move figures are another reason for caution. Investors will watch fourth-quarter volumes, margins, cash conversion against the 121% reported and further repurchases. A persistent gap between GAAP and adjusted earnings would also merit scrutiny.

Where Things Stand

DuPont lifted its outlook because third-quarter adjusted earnings of USD 2.09 beat consensus, Organic Sales grew 5% and the operating EBITDA margin widened by 80 basis points, which supports the new range of USD 7.47 to USD 7.52. Growth is moderate, and part of the earnings lift comes from share repurchases. For DuPont (NYSE:DD), fourth-quarter volumes and cash conversion are the next tests. The size of the share price move is uncertain because reports conflict. Nothing here is Investment advice.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.